SAOWANEE POWELL: Open Payments
NPI 1326717919 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 37 payments from 12 companies in 2025. Trend: 2023 $998 · 2024 $1,158 · 2025 $941
Food & beverage: $811Education: $130
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 9 | $223 |
| Otsuka America Pharmaceutical, Inc. | 7 | $212 |
| Novo Nordisk Inc | 3 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Ardelyx, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Travere Therapeutics, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
Products named: TERLIVAZ, Ozempic, ACTHAR, Kerendia, JYNARQUE, IBSRELA, FARXIGA, Wegovy.
Industry payments across VA — which companies pay providers there.
